Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Xyrem sodium oxybate: Phase IIIb data

In the double-blind Phase IIIb EXCEEDS trial in about 200 patients, treatment with Xyrem alone or in combination

Read the full 184 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE